Dr. Ahmed Mohamed Abdallah is a medical doctor and bioethicist with over 15 years of experience in clinical research, ethics, and public health. He earned his medical degree from Hubert Kairuki Memorial University and later specialized in bioethics at Muhimbili University of Health and Allied Sciences (MUHAS), where he also completed his master’s thesis on research ethics in low-resource settings.
Dr. Abdallah began his clinical research career at the Ifakara Health Research and Development Centre (IHRDC), serving as a study physician for a multicentre Phase III paediatric Coartem trial sponsored by MMV/NOVARTIS (2006–2007) in Bagamoyo, Tanzania. He later joined the KEMRI/Wellcome Trust in Kilifi, Kenya, contributing to multiple antimalarial drug trials—including a MMV/GSK study (2007), an investigator-led study on artemisinin resistance (2007–2008), and a Sanofi-sponsored Phase II trial on ferroquine-artesunate (2008–2009). He also worked as a clinician in the Kilifi District Hospital’s paediatric department during this period.
In 2009–2010, Dr. Abdallah served as Assistant Director at the Public Health Laboratory in Pemba under the Ministry of Health Zanzibar, with support from the Ivo de Carneri Foundation. Since 2011, he has been affiliated with the Tanzania National Institute for Medical Research (NIMR), contributing to numerous national and international collaborations. These include: A 2012 multicentre malaria drug trial with Ifakara Institute. A 2013–2015 HIV vaccine Phase I/II trial with MUHAS in Tanzania and Mozambique. A 2015–2016 Phase III study on HIV-associated cryptococcal meningitis with NIMR Muhimbili. In the field of research ethics, Dr. Abdallah served from 2017 to 2023 as a member and Deputy Vice Chair of the Ifakara Research Review Board. He was also part of the National Health Research Ethics Committee Secretariat (2017–2023), supporting clinical trial oversight and ethics review coordination. From 2023 to 2025, he has been leading the Pandemic Ethics Project in Tanzania and currently serves on the NIMR Accreditation Board.